Publication Name	World Journal of Clinical Cases
Manuscript ID	84458
Country	Italy

Received	2023-03-14 22:55
Peer-Review Started	2023-03-14 22:57
To Make the First Decision
Return for Revision	2023-04-11 01:39
Revised	2023-05-04 07:44
Second Decision	2023-05-24 02:47
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-05-24 07:49
Articles in Press	2023-05-24 07:49
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-05-23 01:13
Typeset the Manuscript	2023-06-01 08:04
Publish the Manuscript Online	2023-09-08 09:38

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Dermatology
Manuscript Type	Case Report
Article Title	Mepolizumab induced palmoplantar psoriasis: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Fabio Artosi, Laura Diluvio, Martina Vultaggio, Elena Campione and Luca Bianchi
ORCID	Author(s) ORCID Number Fabio Artosi http://orcid.org/0000-0002-7636-3532
Funding Agency and Grant Number
Corresponding Author	Fabio Artosi, MD, Academic Fellow, Doctor, Doctor, Department of Systems Medicine, University of Rome “Tor Vergata”, 81 Viale Oxford, Rome 00133, Italy. fabio.artosi994@gmail.com
Key Words	Psoriasis; Interleukin-5; Mepolizumab; Asthma; Immunology; Case report
Core Tip	We report the case of a 59-year-old patient with severe asthma who developed palmar psoriasis after 6 mo from the initiation of treatment with a humanized monoclonal antibody directed against interleukin-5 (IL-5), mepolizumab. There are several case reports of psoriasis induced by dupilumab therapy in the literature, but this phenomenon has not yet been recognized with modulating IL-5R signalling. This article reports the pathogenetic hypotheses that may underlie this phenomenon.
Publish Date	2023-09-08 09:38
Citation	Artosi F, Diluvio L, Vultaggio M, Campione E, Bianchi L. Mepolizumab induced palmoplantar psoriasis: A case report. World J Clin Cases 2023; 11(26): 6154-6158
URL	https://www.wjgnet.com/2307-8960/full/v11/i26/6154.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i26.6154

Full Article (PDF)	WJCC-11-6154-with-cover.pdf
Full Article (Word)	WJCC-11-6154.docx
Manuscript File	84458_Auto_Edited-YLC-Wang TQ-JLW.docx
Answering Reviewers	84458-Answering reviewers.pdf
Audio Core Tip	84458-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	84458-Conflict-of-interest statement.pdf
Copyright License Agreement	84458-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	84458-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	84458-Language certificate.pdf
Peer-review Report	84458-Peer-review(s).pdf
Scientific Misconduct Check	84458-Bing-Chen YL-2.png
Scientific Editor Work List	84458-Scientific editor work list.pdf
CrossCheck Report	84458-CrossCheck report.pdf